Halamid® in combat against EMS (update)

AxcentiveArchive

The Early Mortality Syndrome (EMS), also known as Acute Hepatopancreatic Necrosis Syndrome is causing high mortalities in various Southeast Asian shrimp farming countries. The cause of this disease has been linked to the omnipresent Vibrio parahaemolyticus. However this bacterium alone does not have such disastrous consequences. In fact the toxins produced by a virus that has infected the Vibrio (a … Read More

Halamid® brings Rapid Action against Salmonella

AxcentiveArchive

Although outbreaks have been traced to a variety of food types, Salmonella is most often associated with poultry products and is considered a veritable scourge of our industry. First identified as a human pathogen in the late 19th Century, this successful and aggressive family of bacteria continues to evolve and diversify, to the point where today there are more than … Read More

Halamid® for Poultry markets at VIV Europe 2014

AxcentiveArchive

Axcentive will be exhibiting Halamid® at VIV Europe from 20-22 May 2014 in Utrecht (NL). This year VIV Europe will have more focus on the poultry industry, which is an extremely important market sector for our Universal Disinfectant. Halamid® has a long and well established reputation in the poultry industry which it has served for over 50 years as a … Read More

Halamid® Aqua gains exclusive animal drug status in the USA

AxcentiveArchive

Axcentive is proud to announce the imminent award of a New Animal Drug Application (NADA) approval for the use of Halamid® in aquaculture in the USA; such approval to be granted by FDA’s Center for Veterinary Medicine. All technical sections for this application have been completed and the remaining administrative procedure is expected to take another 2 months. The product … Read More